126 related articles for article (PubMed ID: 35533550)
1. Participation in a government-subsidised colorectal cancer screening programme for asymptomatic individuals in Hong Kong.
Chan DNS; So WKW; Choi KC
Cancer Epidemiol; 2022 Aug; 79():102174. PubMed ID: 35533550
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of population-based colorectal cancer screening programme in down-staging.
Law CC; Wong CHN; Chong PSK; Mang OWK; Lam AWH; Chak MMY; Lee RSP; Wong KH; Ho RKW
Cancer Epidemiol; 2022 Aug; 79():102184. PubMed ID: 35580366
[TBL] [Abstract][Full Text] [Related]
3. Identifying the factors promoting colorectal cancer screening uptake in Hong Kong using Andersen's behavioural model of health services use.
Chan DNS; Choi KC; Au DWH; So WKW
BMC Public Health; 2022 Jun; 22(1):1228. PubMed ID: 35725428
[TBL] [Abstract][Full Text] [Related]
4. Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program.
Koïvogui A; Vincelet C; Abihsera G; Ait-Hadad H; Delattre H; Le Trung T; Bernoux A; Carroll R; Nicolet J
World J Gastroenterol; 2023 Mar; 29(9):1492-1508. PubMed ID: 36998423
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
6. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong.
Huang J; Wang J; Pang TW; Chan MK; Leung S; Chen X; Leung C; Zheng ZJ; Wong MC
BMJ Open; 2020 Aug; 10(8):e037619. PubMed ID: 32764087
[TBL] [Abstract][Full Text] [Related]
7. Recommendations on prevention and screening for colorectal cancer in Hong Kong.
Lam TH; Wong KH; Chan KK; Chan MC; Chao DV; Cheung AN; Fan CY; Ho J; Hui EP; Lam KO; Law CK; Law WL; Loong HH; Ngan RK; Tsang TH; Wong MC; Yeung RM; Ying AC; Ching R
Hong Kong Med J; 2018 Oct; 24(5):521-526. PubMed ID: 30318477
[TBL] [Abstract][Full Text] [Related]
8. Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.
Molina-Barceló A; Peiró-Pérez R; Vanaclocha M; Vallés G; Guaita L; Salas D
Gac Sanit; 2018; 32(1):72-76. PubMed ID: 27745772
[TBL] [Abstract][Full Text] [Related]
9. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
[TBL] [Abstract][Full Text] [Related]
10. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
Koïvogui A; Mab GL; Benamouzig R
Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
[TBL] [Abstract][Full Text] [Related]
11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
12. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer screening behaviour and associated factors among Chinese aged 50 and above in Hong Kong - a population-based survey.
So WK; Choi KC; Chan DN; Shiu AT; Ho SS; Chan HY; Lam WW; Cheng KK; Goggins W; Chan CW
Eur J Oncol Nurs; 2012 Sep; 16(4):413-8. PubMed ID: 22036772
[TBL] [Abstract][Full Text] [Related]
14. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
Blom J; Törnberg S
J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong.
Wong BC; Chan AO; Wong KW; Ching CK; Wong WM; Tam S; Lai KC; Chan CK; Yuen MF; Lam SK
Eur J Cancer Prev; 2005 Apr; 14(2):181-4. PubMed ID: 15785323
[TBL] [Abstract][Full Text] [Related]
16. Reasons for participation and non-participation in colorectal cancer screening.
Berg-Beckhoff G; Leppin A; Nielsen JB
Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
18. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
[TBL] [Abstract][Full Text] [Related]
19. Impact of stopping sending colorectal cancer screening test kits by regular mail.
Koïvogui A; Ecochard R; Le Mab G; Benamouzig R
Public Health; 2019 Aug; 173():33-41. PubMed ID: 31252152
[TBL] [Abstract][Full Text] [Related]
20. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
